Bradley C Leibovich

Summary

Affiliation: Mayo Clinic
Country: USA

Publications

  1. doi request reprint Outcomes following partial nephrectomy by tumor size
    Paul L Crispen
    Department of Urology, Mayo Clinic, Rochester, Minnesota 55905, USA
    J Urol 180:1912-7. 2008
  2. ncbi request reprint Nephron sparing surgery for appropriately selected renal cell carcinoma between 4 and 7 cm results in outcome similar to radical nephrectomy
    Bradley C Leibovich
    Department of Urology, Mayo Medical School and Mayo Clinic, Rochester, Minnesota 55905, USA
    J Urol 171:1066-70. 2004
  3. ncbi request reprint Cancer specific survival for patients with pT3 renal cell carcinoma-can the 2002 primary tumor classification be improved?
    Bradley C Leibovich
    Department of Urology, Mayo Medical School and Mayo Clinic, Rochester, Minnesota 55905, USA
    J Urol 173:716-9. 2005
  4. ncbi request reprint Surgical management of renal cell carcinoma
    Bradley C Leibovich
    Department of Urology, Mayo Medical School, Mayo Clinic, Rochester, MN 55905, USA
    Semin Oncol 33:552-62. 2006
  5. ncbi request reprint Prediction of progression after radical nephrectomy for patients with clear cell renal cell carcinoma: a stratification tool for prospective clinical trials
    Bradley C Leibovich
    Department of Urology, Mayo Medical School and Mayo Clinic, Rochester, Minnesota 55905, USA
    Cancer 97:1663-71. 2003
  6. ncbi request reprint A scoring algorithm to predict survival for patients with metastatic clear cell renal cell carcinoma: a stratification tool for prospective clinical trials
    Bradley C Leibovich
    Department of Urology, Mayo Medical School, Rochester, Minnesota, USA
    J Urol 174:1759-63; discussion 1763. 2005
  7. doi request reprint Histological subtype is an independent predictor of outcome for patients with renal cell carcinoma
    Bradley C Leibovich
    Department of Urology, Mayo Clinic, Rochester, Minnesota 55905, USA
    J Urol 183:1309-15. 2010
  8. doi request reprint Overall survival and development of stage IV chronic kidney disease in patients undergoing partial and radical nephrectomy for benign renal tumors
    Dharam Kaushik
    Department of Urology, Mayo Clinic, Rochester, MN, USA
    Eur Urol 64:600-6. 2013
  9. pmc Association of microvascular and capillary-lymphatic invasion with outcome in patients with renal cell carcinoma
    Manuel S Eisenberg
    Department of Urology, Mayo Clinic, Rochester, Minnesota 55905, USA
    J Urol 190:37-43. 2013
  10. ncbi request reprint Costimulatory molecule B7-H1 in primary and metastatic clear cell renal cell carcinoma
    R Houston Thompson
    Department of Urology, Mayo Medical School, Mayo Clinic, Rochester, Minnesota 55905, USA
    Cancer 104:2084-91. 2005

Detail Information

Publications107 found, 100 shown here

  1. doi request reprint Outcomes following partial nephrectomy by tumor size
    Paul L Crispen
    Department of Urology, Mayo Clinic, Rochester, Minnesota 55905, USA
    J Urol 180:1912-7. 2008
    ..We established long-term survival in patients following partial nephrectomy according to tumor size...
  2. ncbi request reprint Nephron sparing surgery for appropriately selected renal cell carcinoma between 4 and 7 cm results in outcome similar to radical nephrectomy
    Bradley C Leibovich
    Department of Urology, Mayo Medical School and Mayo Clinic, Rochester, Minnesota 55905, USA
    J Urol 171:1066-70. 2004
    ..We compared outcomes between patients treated with nephron sparing surgery (NSS) without imperative indications for renal preservation and radical nephrectomy (RN) for 4 to 7 cm renal cell carcinoma (RCC)...
  3. ncbi request reprint Cancer specific survival for patients with pT3 renal cell carcinoma-can the 2002 primary tumor classification be improved?
    Bradley C Leibovich
    Department of Urology, Mayo Medical School and Mayo Clinic, Rochester, Minnesota 55905, USA
    J Urol 173:716-9. 2005
    ..We evaluated the association of tumor thrombus level and fat invasion with outcome to determine if further subclassification would improve the prognostic accuracy of the current classification...
  4. ncbi request reprint Surgical management of renal cell carcinoma
    Bradley C Leibovich
    Department of Urology, Mayo Medical School, Mayo Clinic, Rochester, MN 55905, USA
    Semin Oncol 33:552-62. 2006
    ..Herein, we discuss the role of surgery for the management of localized and metastatic RCC...
  5. ncbi request reprint Prediction of progression after radical nephrectomy for patients with clear cell renal cell carcinoma: a stratification tool for prospective clinical trials
    Bradley C Leibovich
    Department of Urology, Mayo Medical School and Mayo Clinic, Rochester, Minnesota 55905, USA
    Cancer 97:1663-71. 2003
    ....
  6. ncbi request reprint A scoring algorithm to predict survival for patients with metastatic clear cell renal cell carcinoma: a stratification tool for prospective clinical trials
    Bradley C Leibovich
    Department of Urology, Mayo Medical School, Rochester, Minnesota, USA
    J Urol 174:1759-63; discussion 1763. 2005
    ..We developed a clinically useful scoring algorithm to predict cancer specific survival for patients with clear cell metastatic renal cell carcinoma (RCC)...
  7. doi request reprint Histological subtype is an independent predictor of outcome for patients with renal cell carcinoma
    Bradley C Leibovich
    Department of Urology, Mayo Clinic, Rochester, Minnesota 55905, USA
    J Urol 183:1309-15. 2010
    ..We examined the significance of histological subtype on progression to distant metastasis and cancer specific death after nephrectomy...
  8. doi request reprint Overall survival and development of stage IV chronic kidney disease in patients undergoing partial and radical nephrectomy for benign renal tumors
    Dharam Kaushik
    Department of Urology, Mayo Clinic, Rochester, MN, USA
    Eur Urol 64:600-6. 2013
    ..Although partial nephrectomy (PN) has been associated with improved renal function compared with radical nephrectomy (RN) for renal cell carcinoma, the impact on overall survival (OS) remains controversial...
  9. pmc Association of microvascular and capillary-lymphatic invasion with outcome in patients with renal cell carcinoma
    Manuel S Eisenberg
    Department of Urology, Mayo Clinic, Rochester, Minnesota 55905, USA
    J Urol 190:37-43. 2013
    ..We evaluated the association of microvascular and capillary-lymphatic invasion with patient outcome after nephrectomy for renal cell carcinoma...
  10. ncbi request reprint Costimulatory molecule B7-H1 in primary and metastatic clear cell renal cell carcinoma
    R Houston Thompson
    Department of Urology, Mayo Medical School, Mayo Clinic, Rochester, Minnesota 55905, USA
    Cancer 104:2084-91. 2005
    ..In the current study, the authors updated their primary RCC results with additional follow-up and investigated the potential role of B7-H1 in metastatic RCC...
  11. ncbi request reprint B7-H1 glycoprotein blockade: a novel strategy to enhance immunotherapy in patients with renal cell carcinoma
    R Houston Thompson
    Department of Urology, Mayo Medical School, Mayo Clinic, Rochester, Minnesota 55905, USA
    Urology 66:10-4. 2005
    ..35-9.15; P = 0.010). Tumor-associated B7-H1 expression is significantly associated with poor prognosis among patients with clear-cell RCC. Manipulation of B7-H1 with therapeutic intent remains a realistic and viable therapeutic option...
  12. ncbi request reprint Reclassification of patients with pT3 and pT4 renal cell carcinoma improves prognostic accuracy
    R Houston Thompson
    Department of Urology, Mayo Medical School and Mayo Clinic, Rochester, Minnesota 55905, USA
    Cancer 104:53-60. 2005
    ....
  13. doi request reprint The relationship of postoperative complications with in-hospital outcomes and costs after renal surgery for kidney cancer
    Simon P Kim
    Department of Urology, Mayo Clinic, Mayo Clinic, Rochester, MN 55905, USA
    BJU Int 111:580-8. 2013
    ..Moreover, postoperative complications were associated with higher mortality, length of stay and total costs of hospitalisation...
  14. pmc Dynamic prediction of metastases after radical prostatectomy for prostate cancer
    Brant A Inman
    Division of Urology, Duke University Medical Center, Durham, NC, USA
    BJU Int 108:1762-8. 2011
    ..The net result is a dynamic tool that renders clinically relevant predictions that change as the patient's clinical status changes throughout the postoperative course...
  15. doi request reprint Routine adrenalectomy in patients with locally advanced renal cell cancer does not offer oncologic benefit and places a significant portion of patients at risk for an asynchronous metastasis in a solitary adrenal gland
    Christopher J Weight
    Department of Urology, Mayo Clinic, Rochester, MN 55905, USA
    Eur Urol 60:458-64. 2011
    ..The indications for the removal of the ipsilateral adrenal gland in patients with renal cell carcinoma (RCC) and the long-term outcomes have not been well studied...
  16. doi request reprint Renal function after partial nephrectomy: effect of warm ischemia relative to quantity and quality of preserved kidney
    R Houston Thompson
    Mayo Medical School and Mayo Clinic, Rochester, Minnesota, USA
    Urology 79:356-60. 2012
    ..To evaluate the effects of warm ischemia time (WIT) and quantity and quality of kidney preserved on renal functional recovery after partial nephrectomy (PN). The effect of WIT relative to these other parameters has recently been challenged...
  17. ncbi request reprint Obesity and survival after radical prostatectomy: A 10-year prospective cohort study
    Sameer A Siddiqui
    Department of Urology, Mayo Clinic, Rochester, Minnesota 55905, USA
    Cancer 107:521-9. 2006
    ..Obesity and prostate cancer are among the most common health problems affecting American men today. The authors' goal was to assess the impact of obesity on clinical and pathologic features of prostate cancer and long-term outcomes...
  18. ncbi request reprint Trends in distribution and prognostic significance of Gleason grades on radical retropubic prostatectomy specimens between 1989 and 2001
    Shomik Sengupta
    Department of Urology, Mayo Clinic, Rochester, Minnesota 55905, USA
    Cancer 106:2630-5. 2006
    ..The objectives of the current study were to examine time trends in the prevalence of Gleason grades of prostate cancer on radical retropubic prostatectomy (RRP) specimens and to assess the resultant impact on prognosis...
  19. ncbi request reprint Scoring algorithm to predict survival after nephrectomy and immunotherapy in patients with metastatic renal cell carcinoma: a stratification tool for prospective clinical trials
    Bradley C Leibovich
    University of California Los Angeles Kidney Cancer Program, Department of Urology, University of California Los Angeles School of Medicine, Los Angeles, California 90095 1738, USA
    Cancer 98:2566-75. 2003
    ..The objective of this study was to develop an algorithm capable of stratifying the survival of patients with metastatic renal cell carcinoma (RCC) after nephrectomy and immunotherapy...
  20. ncbi request reprint Survivin and b7-h1 are collaborative predictors of survival and represent potential therapeutic targets for patients with renal cell carcinoma
    Amy E Krambeck
    Department of Urology, Mayo Medical School, Mayo Clinic, Rochester, MN 55905, USA
    Clin Cancer Res 13:1749-56. 2007
    ..Herein, we examine the clinical effect of ccRCC combined expression of both survivin and B7-H1...
  21. pmc Tumor cell and tumor vasculature expression of B7-H3 predict survival in clear cell renal cell carcinoma
    Paul L Crispen
    Department of Urology, Mayo Clinic, Rochester, Minnesota, USA
    Clin Cancer Res 14:5150-7. 2008
    ..As such, we evaluated the association of B7-H3 expression with clinicopathologic outcomes in patients treated for ccRCC...
  22. doi request reprint After radical retropubic prostatectomy 'insignificant' prostate cancer has a risk of progression similar to low-risk 'significant' cancer
    Shomik Sengupta
    Department of Urology, Mayo Clinic, Rochester, MN 55905, USA
    BJU Int 101:170-4. 2008
    ....
  23. doi request reprint Lymph node dissection at the time of radical nephrectomy for high-risk clear cell renal cell carcinoma: indications and recommendations for surgical templates
    Paul L Crispen
    Department of Urology, Mayo Clinic, Rochester, MN 55905, USA
    Eur Urol 59:18-23. 2011
    ..Observational studies suggest a proportion of patients with lymph node metastases will benefit from lymph node dissection (LND) at the time of nephrectomy for clear cell renal cell carcinoma (RCC)...
  24. ncbi request reprint Surgical treatment of renal cell carcinoma in the immunocompromised transplant patient
    Matthew K Tollefson
    Department of Urology, Mayo Medical School and Mayo Clinic, Rochester, Minnesota 55905, USA
    Urology 75:1373-7. 2010
    ..To determine whether iatrogenic immunosuppression used after transplantation infers a poor prognosis of renal cell carcinoma (RCC) as natural negative immune regulators have been associated with decreased cancer-specific survival from RCC...
  25. ncbi request reprint High expression levels of survivin protein independently predict a poor outcome for patients who undergo surgery for clear cell renal cell carcinoma
    Alexander S Parker
    Department of Urology, Mayo Clinic College of Medicine, Jacksonville, Florida, USA
    Cancer 107:37-45. 2006
    ..What remained in question was whether survivin expression at the protein level is an independent predictor of disease progression and cancer-specific survival...
  26. ncbi request reprint Tumor B7-H1 is associated with poor prognosis in renal cell carcinoma patients with long-term follow-up
    R Houston Thompson
    Department of Urology, Mayo Medical School, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
    Cancer Res 66:3381-5. 2006
    ..RCC patients with tumor B7-H1 are at significant risk of rapid cancer progression and accelerated rates of mortality. B7-H1 may function as a key determinant in RCC, abrogating immune responses directed against this immunogenic tumor...
  27. ncbi request reprint Carbonic anhydrase IX is not an independent predictor of outcome for patients with clear cell renal cell carcinoma
    Bradley C Leibovich
    Department of Urology, Mayo Medical School and Mayo Clinic, Rochester, MN 55905, USA
    J Clin Oncol 25:4757-64. 2007
    ..We attempted to validate the prognostic utility of CAIX expression using a large cohort of ccRCC patients with long-term follow-up...
  28. ncbi request reprint Is the GPSM scoring algorithm for patients with prostate cancer valid in the contemporary era?
    R Houston Thompson
    Department of Urology and Division of Biostatistics, Mayo Clinic College of Medicine, Rochester, Minnesota 55905, USA
    J Urol 178:459-63; discussion 463. 2007
    ..It was developed from patients who underwent radical retropubic prostatectomy from 1990 to 1993. We investigated the predictive ability of GPSM in the contemporary era...
  29. ncbi request reprint Is renal sinus fat invasion the same as perinephric fat invasion for pT3a renal cell carcinoma?
    R Houston Thompson
    Department of Urology, Mayo Medical School and Mayo Clinic, Rochester, Minnesota 55905, USA
    J Urol 174:1218-21. 2005
    ..We investigated the prognostic significance of each of these pathological features using a cohort of pT3a patients...
  30. ncbi request reprint Independent validation of the 2002 American Joint Committee on cancer primary tumor classification for renal cell carcinoma using a large, single institution cohort
    Igor Frank
    Department of Urology, Mayo Medical School and Mayo Clinic, Rochester, Minnesota, USA
    J Urol 173:1889-92. 2005
    ..In the current study we evaluated the 2002 primary tumor classification and compared its predictive ability with that of the 1997 classification...
  31. pmc Development and evaluation of BioScore: a biomarker panel to enhance prognostic algorithms for clear cell renal cell carcinoma
    Alexander S Parker
    Department of Urology, Mayo Medical School, Jacksonville, Florida, USA
    Cancer 115:2092-103. 2009
    ..In the current study, they described the creation of a scoring system based on this panel of biomarkers that can be used in tandem with existing clinicopathologic features and algorithms to improve ccRCC outcome prediction...
  32. ncbi request reprint Histologic coagulative tumor necrosis as a prognostic indicator of renal cell carcinoma aggressiveness
    Shomik Sengupta
    Department of Urology, Mayo Medical School and Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
    Cancer 104:511-20. 2005
    ..90; P < 0.001). CONCLUSIONS: Histologic coagulative tumor necrosis is an independent predictor of outcome for clear cell and chromophobe RCC, and it should be routinely reported and used in clinical assessment...
  33. doi request reprint Iatrogenic splenectomy during nephrectomy for renal tumors
    Jeffrey K Wang
    Department of Urology, Mayo Clinic, Rochester, MN, USA
    Int J Urol 20:896-902. 2013
    ..To evaluate risk factors associated with iatrogenic splenectomy during nephrectomy and to assess outcomes among patients undergoing nephrectomy for renal tumors...
  34. doi request reprint Multimodality therapy including surgical resection and intraoperative electron radiotherapy for recurrent or advanced primary carcinoma of the urinary bladder or ureter
    Christopher L Hallemeier
    Departments of Radiation Oncology Urology, Mayo Clinic, Rochester, MN Department of Radiation Oncology, Mayo Clinic, Scottsdale, AZ
    Am J Clin Oncol 36:596-600. 2013
    ..To report outcomes of multimodality therapy incorporating surgical resection and intraoperative electron radiotherapy (IOERT) for patients with locoregionally (LR) recurrent or advanced primary urothelial carcinoma...
  35. pmc The impact of histology on clinicopathologic outcomes for patients with renal cell carcinoma and venous tumor thrombus: a matched cohort analysis
    Dharam Kaushik
    Department of Urology, Mayo Clinic, Rochester, MN, USA
    Urology 82:136-41. 2013
    ..To evaluate the impact of tumor histology on clinicopathologic outcomes for patients with renal cell carcinoma (RCC) and venous tumor thrombus (VTT)...
  36. ncbi request reprint Tumor-infiltrating Foxp3-CD4+CD25+ T cells predict poor survival in renal cell carcinoma
    Sameer A Siddiqui
    Department of Urology, Mayo Clinic, Rochester, Minnesota 55905, USA
    Clin Cancer Res 13:2075-81. 2007
    ..We tested for the presence of putative Tregs within renal cell carcinoma (RCC) tumors...
  37. pmc Long-term outcomes of radical prostatectomy with multimodal adjuvant therapy in men with a preoperative serum prostate-specific antigen level > or =50 ng/mL
    Brant A Inman
    Department of Urology, Mayo Clinic College of Medicine, Rochester, Minnesota 55905, USA
    Cancer 113:1544-51. 2008
    ..The authors evaluated the long-term outcomes of men with prostate cancer and very high (> or =50 ng/mL) preoperative serum prostate-specific antigen (PSA) values that were treated with radical prostatectomy...
  38. pmc External validation of IMP3 expression as an independent prognostic marker for metastatic progression and death for patients with clear cell renal cell carcinoma
    Nathan E Hoffmann
    Department of Urology, Mayo Clinic, Rochester, Minnesota 55905, USA
    Cancer 112:1471-9. 2008
    ....
  39. ncbi request reprint A multifactorial postoperative surveillance model for patients with surgically treated clear cell renal cell carcinoma
    Igor Frank
    Department of Urology, Mayo Medical School and Mayo Clinic, Rochester, Minnesota, USA
    J Urol 170:2225-32. 2003
    ..We designed scoring algorithms for postoperative surveillance based on multivariately significant predictors of site specific disease recurrence...
  40. pmc B7-H4 expression in renal cell carcinoma and tumor vasculature: associations with cancer progression and survival
    Amy E Krambeck
    Department of Urology, Mayo Medical School, Mayo Clinic, Rochester, MN 55905, USA
    Proc Natl Acad Sci U S A 103:10391-6. 2006
    ..Last, we demonstrate that patients with RCC tumors expressing both B7-H4 and B7-H1 are at an even greater risk of death from RCC...
  41. ncbi request reprint Patients with pT1 renal cell carcinoma who die from disease after nephrectomy may have unrecognized renal sinus fat invasion
    Robert Houston Thompson
    Department of Urology, Mayo Medical School and Mayo Clinic, Rochester, MN 55905, USA
    Am J Surg Pathol 31:1089-93. 2007
    ..Appropriate assessment of nephrectomy specimens should include proper sampling of the renal sinus even for seemingly localized tumors...
  42. ncbi request reprint Ki-67 and coagulative tumor necrosis are independent predictors of poor outcome for patients with clear cell renal cell carcinoma and not surrogates for each other
    Matthew K Tollefson
    Department of Urology, Mayo Clinic and Mayo Medical School, Rochester, MN 55905, USA
    Cancer 110:783-90. 2007
    ..Thus, the goal was to directly test whether Ki-67 and necrosis convey similar or distinct information for the prognostic assessment of ccRCC...
  43. ncbi request reprint Mononuclear cell infiltration in clear-cell renal cell carcinoma independently predicts patient survival
    W Scott Webster
    Department of Urology, Mayo Clinic, Rochester, Minnesota 55905, USA
    Cancer 107:46-53. 2006
    ..The objective of the current study was to evaluate associations between mononuclear cell infiltration in routinely prepared paraffin-embedded specimens with survival in patients with clear-cell RCC...
  44. doi request reprint Carbonic anhydrase IX (CAIX) is not an independent predictor of outcome in patients with clear cell renal cell carcinoma (ccRCC) after long-term follow-up
    Ben Y Zhang
    Department of Internal Medicine, Mayo Clinic and Mayo Medical School, 200 First Street SW, Rochester, MN 55905, USA
    BJU Int 111:1046-53. 2013
    ..With recent smaller studies showing conflicting results, we aimed to update our initial analysis in 2007 with an additional 5-year follow-up...
  45. doi request reprint Practice-setting and surgeon characteristics heavily influence the decision to perform partial nephrectomy among American Urologic Association surgeons
    Christopher J Weight
    Department of Urology, Mayo Clinic, Rochester, MN, USA
    BJU Int 111:731-8. 2013
    ..We observe that high-volume renal surgeons have different thresholds of 'technical feasibility'...
  46. doi request reprint Comparative effectiveness for survival and renal function of partial and radical nephrectomy for localized renal tumors: a systematic review and meta-analysis
    Simon P Kim
    Department of Urology, Mayo Clinic, Rochester, Minnesota 55905, USA
    J Urol 188:51-7. 2012
    ..We performed a systematic review and meta-analysis of partial vs radical nephrectomy for localized renal tumors, considering all cause and cancer specific mortality, and severe chronic kidney disease...
  47. doi request reprint Treatment of patients with small renal masses: a survey of the American Urological Association
    Rodney H Breau
    Department of Urology, Mayo Clinic, Rochester, Minnesota 55901, USA
    J Urol 185:407-13. 2011
    ..We surveyed American Urological Association members to determine factors that influence the treatment of patients with small renal masses...
  48. ncbi request reprint Should direct ipsilateral adrenal invasion from renal cell carcinoma be classified as pT3a?
    R Houston Thompson
    Department of Urology, Mayo Medical School and Mayo Clinic, Rochester, Minnesota 55905, USA
    J Urol 173:918-21. 2005
    ..In the current study we evaluated the association of direct ipsilateral adrenal invasion with outcome to determine if reclassification of these tumors as pT4 would improve the accuracy of the current tumor classification...
  49. ncbi request reprint The preoperative erythrocyte sedimentation rate is an independent prognostic factor in renal cell carcinoma
    Shomik Sengupta
    Department of Urology, Mayo Clinic, Rochester, Minnesota 55905, USA
    Cancer 106:304-12. 2006
    ..Hence, the current study was conducted to expand on prior observations pertaining to the ESR as a prognostic indicator in patients with RCC...
  50. ncbi request reprint Increasing prostate specific antigen following radical prostatectomy and adjuvant hormonal therapy: doubling time predicts survival
    Shomik Sengupta
    Department of Urology, Mayo Clinic, Rochester, Minnesota 55905, USA
    J Urol 175:1684-90; discussion 1690. 2006
    ..We assessed the natural history of detectable PSA in such patients with particular emphasis on the prognostic usefulness of PSADT...
  51. ncbi request reprint A protocol for performing extended lymph node dissection using primary tumor pathological features for patients treated with radical nephrectomy for clear cell renal cell carcinoma
    Michael L Blute
    Department of Urology, Mayo Clinic, Rochester, Minnesota 55905, USA
    J Urol 172:465-9. 2004
    ....
  52. ncbi request reprint Stratification of patient risk based on prostate-specific antigen doubling time after radical retropubic prostatectomy
    Matthew K Tollefson
    Department of Urology, College of Medicine, Mayo Clinic, 200 First St SW, Rochester, MN 55905, USA
    Mayo Clin Proc 82:422-7. 2007
    ....
  53. ncbi request reprint Percutaneous cryoablation of renal masses >or=3 cm: efficacy and safety in treatment of 108 patients
    Grant D Schmit
    Department of Radiology, Mayo Clinic, Rochester, Minnesota 55905, USA
    J Endourol 24:1255-62. 2010
    ..To evaluate our single institution experience with percutaneous cryoablation of renal masses >or=3 cm in diameter for complications and short-term outcomes...
  54. doi request reprint Percutaneous renal cryoablation: local control at mean 26 months of followup
    Thomas D Atwell
    Department of Radiology, Mayo Clinic, Rochester, Minnesota 55902, USA
    J Urol 184:1291-5. 2010
    ..We retrospectively determined the efficacy of percutaneous renal cryoablation based on a mean followup of more than 2 years...
  55. doi request reprint Percutaneous ablation of renal masses measuring 3.0 cm and smaller: comparative local control and complications after radiofrequency ablation and cryoablation
    Thomas D Atwell
    Department of Diagnostic Radiology, Mayo Clinic, 200 First St SW, Rochester, MN 55902, USA
    AJR Am J Roentgenol 200:461-6. 2013
    ..The purpose of this article is to compare the efficacy and complication rates of percutaneous radiofrequency ablation (RFA) and cryoablation in the treatment of renal masses measuring 3.0 cm and smaller...
  56. ncbi request reprint Assessment of the pathologic inclusion criteria from contemporary adjuvant clinical trials for predicting disease progression after nephrectomy for renal cell carcinoma
    Simon P Kim
    Department of Urology, Mayo Clinic, Rochester, MN, USA
    Cancer 118:4412-20. 2012
    ..The objective of this study was to evaluate the accuracy of the pathologic inclusion criteria from all contemporary adjuvant trials in predicting disease progression (DP) for renal cell carcinoma (RCC)...
  57. doi request reprint Complications following 573 percutaneous renal radiofrequency and cryoablation procedures
    Thomas D Atwell
    Department of Radiology, Mayo Clinic, 200 First St SW, Rochester, MN 55902, USA
    J Vasc Interv Radiol 23:48-54. 2012
    ..To review complications related to percutaneous renal tumor ablation...
  58. doi request reprint Metastatic potential of a renal mass according to original tumour size at presentation
    Eric C Umbreit
    Department of Urology, Mayo Clinic, Rochester, MN, USA
    BJU Int 109:190-4; discussion 194. 2012
    ..To determine the metastatic potential of renal masses based on original tumour size...
  59. doi request reprint Surgical management, complications, and outcome of radical nephrectomy with inferior vena cava tumor thrombectomy facilitated by vascular bypass
    Candace F Granberg
    Department of Urology, Mayo Medical School and Mayo Clinic, Rochester, Minnesota 55905, USA
    Urology 72:148-52. 2008
    ..The indications and results for venovenous bypass (VVB) versus cardiopulmonary bypass (CPB) were reviewed as well...
  60. pmc Predicting disease progression after nephrectomy for localized renal cell carcinoma: the utility of prognostic models and molecular biomarkers
    Paul L Crispen
    Department of Urology, Mayo Clinic, Rochester, Minnesota 55902, USA
    Cancer 113:450-60. 2008
    ..As such, the authors review the current prognostic tools for predicting disease progression for localized RCC, and detail studies to date that have evaluated various biomarkers in this setting...
  61. doi request reprint T-cell coregulatory molecule expression in urothelial cell carcinoma: clinicopathologic correlations and association with survival
    Stephen A Boorjian
    Department of Urology, Mayo Medical School and Mayo Clinic, Rochester, Minnesota 55905, USA
    Clin Cancer Res 14:4800-8. 2008
    ..We evaluated expression of the T-cell coregulators B7-H1, B7-H3, and PD-1 in urothelial cell carcinoma (UCC) of the bladder...
  62. doi request reprint Every minute counts when the renal hilum is clamped during partial nephrectomy
    R Houston Thompson
    Department of Urology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
    Eur Urol 58:340-5. 2010
    ..The safe duration of warm ischemia during partial nephrectomy remains controversial...
  63. pmc Comparison of digital image analysis versus visual assessment to assess survivin expression as an independent predictor of survival for patients with clear cell renal cell carcinoma
    Alexander S Parker
    Department of Urology, Mayo Clinic College of Medicine, Jacksonville, FL 32224, USA
    Hum Pathol 39:1176-84. 2008
    ..Thus, visual assessment represents an economical, widely available, and reliable method to assess survivin as a predictor of clear cell renal cell carcinoma patient outcomes...
  64. doi request reprint Postoperative surveillance for renal cell carcinoma: a multifactorial histological subtype specific protocol
    Sameer A Siddiqui
    Department of Urology, Mayo Clinic, Rochester, MN, USA
    BJU Int 104:778-85. 2009
    ....
  65. pmc Association of abnormal preoperative laboratory values with survival after radical nephrectomy for clinically confined clear cell renal cell carcinoma
    James S Magera
    Department of Urology, Mayo Clinic, Rochester, Minnesota 55905, USA
    Urology 71:278-82. 2008
    ..To determine whether preoperative laboratory values are independently associated with death from clinically confined clear cell renal cell carcinoma (RCC) after radical nephrectomy...
  66. ncbi request reprint PD-1 is expressed by tumor-infiltrating immune cells and is associated with poor outcome for patients with renal cell carcinoma
    R Houston Thompson
    Department of Urology, Mayo Medical School, Mayo Clinic, Rochester, MN 55905, USA
    Clin Cancer Res 13:1757-61. 2007
    ..Levels of immune cells expressing PD-1 (PD-1(+)) in clinical RCC tumors have not been evaluated. Thus, we tested whether immune cell PD-1 expression is observed within aggressive RCC tumors...
  67. ncbi request reprint Greater body mass index is associated with better pathologic features and improved outcome among patients treated surgically for clear cell renal cell carcinoma
    Alexander S Parker
    Department of Urology, Mayo Clinic Jacksonville, Jacksonville, Florida 32224, USA
    Urology 68:741-6. 2006
    ..We used data from a large cohort of patients treated surgically for clear cell RCC to evaluate the association of obesity with the pathologic features of tumor aggressiveness and cancer-specific outcomes...
  68. pmc T-cell co-regulatory molecule expression in renal angiomyolipoma and pulmonary lymphangioleiomyomatosis
    Stephen A Boorjian
    Department of Urology, Mayo Medical School and Mayo Clinic, Rochester, Minnesota 55905, USA
    Urology 74:1359-64. 2009
    ..AML is a highly vascular tumor that most frequently emanates from the kidney. Events leading to its pathogenesis remain enigmatic and understudied...
  69. ncbi request reprint Results of inferior vena caval interruption by greenfield filter, ligation or resection during radical nephrectomy and tumor thrombectomy
    Michael L Blute
    Department of Urology, Mayo Medical School and Mayo Clinic, Rochester, Minnesota, USA
    J Urol 178:440-5; discussion 444. 2007
    ..We describe the indications, technique, complications and outcomes of vena caval interruption during nephrectomy with tumor thrombectomy...
  70. ncbi request reprint Clear cell renal cell carcinoma: gene expression analyses identify a potential signature for tumor aggressiveness
    Farhad Kosari
    Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota 55905, USA
    Clin Cancer Res 11:5128-39. 2005
    ..The objective of this study was to use gene expression profiling to identify novel biomarkers that are predictive of aggressive behavior in clear cell renal cell carcinoma (CCRCC)...
  71. ncbi request reprint Radical nephrectomy for pT1a renal masses may be associated with decreased overall survival compared with partial nephrectomy
    R Houston Thompson
    Department of Urology, Mayo Medical School and Mayo Clinic, Rochester, Minnesota, USA
    J Urol 179:468-71; discussion 472-3. 2008
    ..We reviewed our surgical experience with small renal tumors, comparing overall survival in patients treated with radical and partial nephrectomy...
  72. ncbi request reprint Impact of tumor size on the predictive ability of the pT3a primary tumor classification for renal cell carcinoma
    Sameer A Siddiqui
    Department of Urology, Mayo Clinic, Rochester, Minnesota 55905, USA
    J Urol 177:59-62. 2007
    ..We investigated the association of perinephric and renal sinus fat invasion with death from renal cell carcinoma independent of tumor size...
  73. ncbi request reprint Dynamic outcome prediction in patients with clear cell renal cell carcinoma treated with radical nephrectomy: the D-SSIGN score
    R Houston Thompson
    Department of Urology, Health Sciences Research, Mayo Medical School, Mayo Clinic, Rochester, Minnesota, USA
    J Urol 177:477-80. 2007
    ..We created a dynamic outcome prediction model for continual surveillance that accounts for the disease-free interval following surgery...
  74. ncbi request reprint Sarcomatoid renal cell carcinoma: an examination of underlying histologic subtype and an analysis of associations with patient outcome
    John C Cheville
    Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN 55905, USA
    Am J Surg Pathol 28:435-41. 2004
    ..59; P = 0.010) and after adjusting for TNM stage, tumor size, and histologic tumor necrosis (risk ratio 1.46; P = 0.037)...
  75. ncbi request reprint Complications of contemporary open nephron sparing surgery: a single institution experience
    R Houston Thompson
    Department of Urology, Mayo Medical School and Mayo Clinic, Rochester, Minnesota 55905, USA
    J Urol 174:855-8. 2005
    ..We reviewed our experience with contemporary open NSS, comparing complication rates to those of historical controls and updating data for comparison with minimally invasive procedures...
  76. doi request reprint Outcomes and clinicopathologic variables associated with late recurrence after nephrectomy for localized renal cell carcinoma
    Simon P Kim
    Department of Urology, Mayo Clinic, Rochester, Minnesota 55905, USA
    Urology 78:1101-6. 2011
    ..To characterize the incidence and clinicopathologic factors associated with late recurrence after surgical resection for renal cell carcinoma (RCC) because the recurrence patterns >5 years after nephrectomy have been poorly described...
  77. ncbi request reprint Carbonic anhydrase IX is an independent predictor of survival in advanced renal clear cell carcinoma: implications for prognosis and therapy
    Matthew H T Bui
    Department of Urology, University of California, Los Angeles, California 90095 1738, USA
    Clin Cancer Res 9:802-11. 2003
    ..To date, there are no molecular markers which can reliably predict RCC outcome. We investigated whether a novel kidney cancer marker, carbonic anhydrase IX (CAIX), is associated with progression and survival...
  78. doi request reprint Lymph node dissection in the management of renal cell carcinoma
    Bradley C Leibovich
    Mayo Clinic, 200 First Street, SW, Rochester, MN 55905, USA
    Urol Clin North Am 35:673-8; viii. 2008
    ..This article examines the rationale for lymphadenectomy in the management of renal cell carcinoma and reviews the limited literature on the subject...
  79. ncbi request reprint Should there be a size limit for elective nephron-sparing surgery?
    Kent G Krejci
    Department of Urology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
    Curr Urol Rep 4:21-9. 2003
    ..Current data clearly support the use of elective NSS for localized solid renal masses under 4 cm in size...
  80. ncbi request reprint Surgical treatment of stage pT3b renal cell carcinoma in solitary kidneys: a case series
    Shomik Sengupta
    Urology Department, Mayo Clinic, Rochester, MN, USA
    BJU Int 96:54-7. 2005
    ..To describe the surgical management of patients with renal cell carcinoma (RCC) in a solitary kidney (managed preferentially by nephron-sparing surgery, NSS, to avoid dialysis) and extending into the renal vein or inferior vena cava (T3b)...
  81. ncbi request reprint Is post-chemotherapy resection of seminomatous elements associated with higher acute morbidity?
    Ashraf A Mosharafa
    Department of Urology, Indiana University School of Medicine, Indianapolis, Indiana, USA
    J Urol 169:2126-8. 2003
    ..We examined the impact of seminomatous elements on the rate of complications and the need for additional intraoperative procedures in patients undergoing post-chemotherapy retroperitoneal lymph node dissection...
  82. ncbi request reprint How long is too long? The effect of the duration of anaesthesia on the incidence of non-urological complications after surgery
    Jonathan C Routh
    Department of Urology, Mayo Clinic, Rochester, MN 55905, USA
    BJU Int 102:301-4. 2008
    ....
  83. doi request reprint Radical retropubic prostatectomy in immunosuppressed transplant recipients
    R Houston Thompson
    Department of Urology, Mayo Medical School and Mayo Clinic, Rochester, Minnesota 55902, USA
    J Urol 179:1349-52; discussion 1352-3. 2008
    ..We reviewed our experience with radical retropubic prostatectomy in patients with solid organ transplants...
  84. ncbi request reprint Loss of expression of von Hippel-Lindau tumor suppressor protein associated with improved survival in patients with early-stage clear cell renal cell carcinoma
    Alexander S Parker
    Department of Urology, Mayo Clinic Jacksonville, Jacksonville, Florida 32224, USA
    Urology 65:1090-5. 2005
    ..Recent data have suggested that somatic mutations of the VHL tumor suppressor gene are associated with better cancer-specific survival in patients with CC-RCC...
  85. ncbi request reprint pT2 classification for renal cell carcinoma. Can its accuracy be improved?
    Igor Frank
    Department of Urology, Mayo Medical School and Mayo Clinic, Rochester, Minnesota 55905, USA
    J Urol 173:380-4. 2005
    ..In this study we determined whether a size cutoff point exists within pT2 tumors and whether such subclassification would further improve the accuracy of the current tumor classification...
  86. ncbi request reprint The Mayo Clinic experience with surgical management, complications and outcome for patients with renal cell carcinoma and venous tumour thrombus
    Michael L Blute
    Department of Urology, Mayo Clinic, Rochester, Minnesota 55905, USA
    BJU Int 94:33-41. 2004
    ..To report the surgical management, complications and outcomes over three decades by tumour thrombus level for patients with renal cell carcinoma (RCC) and renal venous extension, as surgery is the most effective treatment...
  87. ncbi request reprint Epididymo-orchitis and testicular abscess due to Nocardia asteroides complex
    Jonathan C Routh
    Department of Urology, Mayo Clinic, Rochester, Minnesota 55901, USA
    Urology 65:591. 2005
    ..Sulfa therapy was begun. In previous case reports, this condition carried a 50% mortality rate. Patients who survive seemed to benefit from aggressive surgical debridement and long-term sulfa therapy...
  88. ncbi request reprint Adjuvant external radiation therapy following radical prostatectomy for node-negative prostate cancer
    Brian J Davis
    Division of Radiation Oncology and Department of Urology, Mayo Clinic and Foundation, Rochester, Minnesota 55905, USA
    Curr Opin Urol 13:117-22. 2003
    ..The use of adjuvant radiation therapy following prostatectomy is commonplace. The purpose of this review is to summarize completed and ongoing clinical trials and to review recent relevant studies and debates related to this subject...
  89. ncbi request reprint Applications of positron emission tomography imaging, intraoperative ultrasonography, magnetic resonance imaging, and angiography in the evaluation of renal masses
    R Houston Thompson
    Department of Urology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
    Curr Urol Rep 5:30-4. 2004
    ....
  90. ncbi request reprint Number of metastatic sites rather than location dictates overall survival of patients with node-negative metastatic renal cell carcinoma
    Ken ryu Han
    Department of Urology, University of California, Los Angeles, School of Medicine, Los Angeles, CA 90095, USA
    Urology 61:314-9. 2003
    ..The most common sites of metastatic renal cell carcinoma (mRCC) are the lung and bone...
  91. ncbi request reprint History of urinary tract infection and risk of renal cell carcinoma
    Alexander S Parker
    Department of Health Sciences Research, Mayo Clinic, Rochester, MN 55905, USA
    Am J Epidemiol 159:42-8. 2004
    ..Results suggest a positive association of UTI history with RCC development, with elevated risks most notable for males with a history of smoking...
  92. ncbi request reprint Adenocarcinoma of the prostate: epidemiological trends, screening, diagnosis, and surgical management of localized disease
    Jonathan C Routh
    Department of Urology, Mayo Clinic College of Medicine, 200 First St SW, Rochester, MN 55905, USA
    Mayo Clin Proc 80:899-907. 2005
    ..In all, this article aims to give the reader a broad overview of the basic elements of prostate cancer diagnosis and surgical treatment in the modem era...
  93. ncbi request reprint Surgical resection of isolated retroperitoneal lymph node recurrence of renal cell carcinoma following nephrectomy
    Stephen A Boorjian
    Department of Urology, Mayo Medical School and Mayo Clinic, Rochester, Minnesota, USA
    J Urol 180:99-103; discussion 103. 2008
    ..We report our experience with resection of isolated retroperitoneal lymph node recurrence...
  94. ncbi request reprint Percutaneous cryoablation of large renal masses: technical feasibility and short-term outcome
    Thomas D Atwell
    Department of Radiology, Mayo Clinic, 200 1st St SW, Rochester, MN 55902, USA
    AJR Am J Roentgenol 188:1195-200. 2007
    ..This retrospective study was performed to assess the feasibility, safety, and short-term outcome of percutaneous cryoablation of large solid renal tumors...
  95. ncbi request reprint Percutaneous cryoablation of 40 solid renal tumors with US guidance and CT monitoring: initial experience
    Thomas D Atwell
    Department of Radiology, Mayo Clinic, Rochester, MN 55905, USA
    Radiology 243:276-83. 2007
    ..To retrospectively determine the safety and effectiveness of percutaneous cryoablation, monitored with computed tomography (CT), for the treatment of solid renal masses...
  96. ncbi request reprint Contemporary imaging modalities for the surveillance of patients with renal cell carcinoma
    Matthew K Tollefson
    Department of Urology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
    Curr Urol Rep 8:38-43. 2007
    ..Herein we review the relevance of these modalities to the follow-up of patients with renal cell carcinoma...
  97. doi request reprint Gadolinium enhanced magnetic resonance urography for upper urinary tract malignancy
    Naoki Takahashi
    Department of Radiology, Mayo Clinic, Rochester, Minnesota 55905, USA
    J Urol 183:1330-65. 2010
    ..We retrospectively evaluated the accuracy of gadolinium enhanced magnetic resonance urography to detect upper urinary tract tumors...
  98. ncbi request reprint The role of nephron sparing surgery for metastatic (pM1) renal cell carcinoma
    Amy E Krambeck
    Department of Urology, Mayo Medical School and Mayo Clinic, Rochester, Minnesota 55905, USA
    J Urol 176:1990-5; discussion 1995. 2006
    ..Studies have demonstrated increased time to progression when cytoreductive nephrectomy is performed for metastatic renal cell carcinoma. We evaluated the role of nephron sparing surgery in these patients...
  99. ncbi request reprint Impact of Parkinson's disease on continence after radical prostatectomy
    Jonathan C Routh
    Department of Urology, Mayo Clinic, Rochester, Minnesota 55901, USA
    Urology 68:575-7. 2006
    ..Thus, it is possible that men with PD have been denied a potentially curative surgery only on the basis of long-standing assumptions. We addressed this issue by examining a cohort of men with PD who underwent RP at our institution...
  100. doi request reprint Comparison of warm ischemia versus no ischemia during partial nephrectomy on a solitary kidney
    R Houston Thompson
    Department of Urology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
    Eur Urol 58:331-6. 2010
    ..The safe duration of warm ischemia during partial nephrectomy (PN) remains controversial...
  101. ncbi request reprint Outcomes of Gleason score 10 prostate carcinoma treated by radical prostatectomy
    Brant A Inman
    Department of Urology, Mayo Clinic College of Medicine, Rochester, Minnesota 55905, USA
    Urology 68:604-8. 2006
    ..Controversy exists as to which form of therapy is most effective for high-grade prostate cancer (PCa)...